×

News publications and other organizations are encouraged to reuse Direct Relief-published content for free under a Creative Commons License (Attribution-Non-Commercial-No Derivatives 4.0 International), given the republisher complies with the requirements identified below.

When republishing:

  • Include a byline with the reporter’s name and Direct Relief in the following format: "Author Name, Direct Relief." If attribution in that format is not possible, include the following language at the top of the story: "This story was originally published by Direct Relief."
  • If publishing online, please link to the original URL of the story.
  • Maintain any tagline at the bottom of the story.
  • With Direct Relief's permission, news publications can make changes such as localizing the content for a particular area, using a different headline, or shortening story text. To confirm edits are acceptable, please check with Direct Relief by clicking this link.
  • If new content is added to the original story — for example, a comment from a local official — a note with language to the effect of the following must be included: "Additional reporting by [reporter and organization]."
  • If republished stories are shared on social media, Direct Relief appreciates being tagged in the posts:
    • Twitter (@DirectRelief)
    • Facebook (@DirectRelief)
    • Instagram (@DirectRelief)

Republishing Images:

Unless stated otherwise, images shot by Direct Relief may be republished for non-commercial purposes with proper attribution, given the republisher complies with the requirements identified below.

  • Maintain correct caption information.
  • Credit the photographer and Direct Relief in the caption. For example: "First and Last Name / Direct Relief."
  • Do not digitally alter images.

Direct Relief often contracts with freelance photographers who usually, but not always, allow their work to be published by Direct Relief’s media partners. Contact Direct Relief for permission to use images in which Direct Relief is not credited in the caption by clicking here.

Other Requirements:

  • Do not state or imply that donations to any third-party organization support Direct Relief's work.
  • Republishers may not sell Direct Relief's content.
  • Direct Relief's work is prohibited from populating web pages designed to improve rankings on search engines or solely to gain revenue from network-based advertisements.
  • Advance permission is required to translate Direct Relief's stories into a language different from the original language of publication. To inquire, contact us here.
  • If Direct Relief requests a change to or removal of republished Direct Relief content from a site or on-air, the republisher must comply.

For any additional questions about republishing Direct Relief content, please email the team here.

Transforming the Lives of Cystic Fibrosis Patients in Lebanon

News

Rare Disease

Rita and her mother are seen as Rita receives cystic fibrosis treatment through Anera's partnership with Direct Relief. (Courtesy photo)

Editor’s note: This article was originally published by Anera here.

Cystic fibrosis is a life-threatening genetic disease affecting the lungs and digestive system. In Lebanon, access to treatment is limited, leaving families to face overwhelming financial and emotional burdens. Many patients endure frequent hospitalizations — sometimes several times every month — just to manage daily symptoms.

In 2024, Anera, in partnership with Direct Relief, launched a life-changing program to make essential cystic fibrosis treatment available in Lebanon. The initiative has brought hope and life-saving treatment to patients who previously had little chance of accessing this critical care.

For Rita, a 29-year-old woman from Douris Village in Bekaa, the hospital was a constant part of her life:

“The hospital was part of my childhood. I used to visit multiple times every month. My lungs were constantly infected, and everyday tasks like walking or even breathing became a battle.”

“During my search for a cure, I discovered a medication in the United States that could change everything — but it was far beyond what my family could afford,” Rita continued. “My father had passed away, and my mother was caring for me and my sister, who also has cystic fibrosis. It felt impossible to access this life-saving treatment.”

After months of intensive coordination with the Ministry of Public Health, the Minister himself, specialist physicians, and the American University of Beirut Medical Center, Anera, through the support of Direct Relief, was finally able to secure this medication for Lebanon at the national level. Crucially, it is now available for the long term, ensuring sustained access for patients who rely on it.

“Seven hours after taking the medication, my body started clearing mucus like never before. In just a few days, I could breathe normally, my appetite returned, and I regained strength.”

“From visiting the hospital multiple times every month, I now need only one visit a year. My sister and I call it ‘the miracle drug.’ This medicine gave me a new breath and a chance to finally pursue my dream of studying media.”

Since the program’s launch, many cystic fibrosis patients in Lebanon have experienced improved health and renewed hope for the future. Since the program’s launch in December 2024, it has brought together all identified cystic fibrosis patients in Lebanon and supported the establishment of the country’s first cystic fibrosis registry.

This registry aims not only to document all known patients but also to reach those who have not yet been informed about the project. As a result, many cystic fibrosis patients have experienced improved health outcomes and a renewed sense of hope for the future.

“To all cystic fibrosis patients, my message is simple: do not give up. Do not let sadness consume you. Your family and community can be your strength. Be strong … You are not alone.”

Giving is Good Medicine

You don't have to donate. That's why it's so extraordinary if you do.

Receive Alerts